The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Etctn 10388: A phase I trial of triapine and lutetium Lu 177 dotatate in well-differentiated somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
 
Aman Chauhan
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology (Inst)
Travel, Accommodations, Expenses - Entrinsic Health Solutions
(OPTIONAL) Uncompensated Relationships - Ipsen (Inst); Lexicon (Inst)
 
Charles Kunos
No Relationships to Disclose
 
Riham El Khouli
No Relationships to Disclose
 
Jill Kolesar
Stock and Other Ownership Interests - Helix Diagnostics
 
Heidi Weiss
No Relationships to Disclose
 
William Edgar Carson
No Relationships to Disclose
 
Mark B Evers
No Relationships to Disclose
 
Mark S. Kidd
No Relationships to Disclose
 
Jan Hendrik Beumer
Employment - Cardinal Health (I); Voisin Consulting (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Research Funding - Abbvie (Inst); Spectrum Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Sulphoraphane for melanoma chemoprevention (Inst)
 
Susanne M. Arnold
Research Funding - Amgen (Inst); AstraZeneca (Inst); Exelixis (Inst); Genentech (Inst); Kura Oncology (Inst); Merck Sharp & Dohme (Inst); National Cancer Institute (Inst); Nektar (Inst); Ohio State University (Inst)
 
Elise C. Kohn
No Relationships to Disclose
 
Lowell Brian Anthony
Consulting or Advisory Role - Lexicon
Research Funding - Abbvie (Inst); Entrinsic Health Solutions (Inst); Oncotelic (Inst)